Retrieve available abstracts of 67 articles: HTML format
Single Articles
May 2025
POLO-SILVEIRA L, Dusza SW, Kentley J, Marchetti MA, et al Cutaneous Melanoma Risk Assessment Among Individuals with a High-Risk Nevus
Phenotype.
J Invest Dermatol. 2025 May 13:S0022-202X(25)00478. PubMed
April 2025
DONG L, Wu N, Cai Z, Yan S, et al Tolerogenic monocyte-derived langerhans cells promote melanoma progression and
immunotherapy resistance through AhR-COX2 activation.
J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00404. PubMedAbstract available
SU L, Wang D, Purwin TJ, Ran S, et al Selective USP7 inhibition synergizes with MEK1/2 inhibitor to enhance immune
responses and potentiate anti-PD-1 therapy in NRAS mutant melanoma.
J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00384. PubMedAbstract available
XIE J, Ma C, Zhao S, Wu D, et al Deubiquitination by USP7 Stabilizes JunD and Activates AIFM2 (FSP1) to Inhibit
Ferroptosis in Melanoma.
J Invest Dermatol. 2025 Apr 3:S0022-202X(25)00381. PubMedAbstract available
March 2025
HAUGH AM, Fisher DE, Lawrence DP Tumor-Infiltrating Lymphocyte Therapy for Melanoma Has Arrived (at Last).
J Invest Dermatol. 2025 Mar 27:S0022-202X(24)03033. PubMed
ZHENG L, Soyer HP, Janda M, Jayasinghe D, et al An overview of data analysis approaches and biases in unveiling the impact of
COVID 19 on melanoma diagnosis.
J Invest Dermatol. 2025 Mar 25:S0022-202X(25)00371. PubMed
MARGUIER A, Mathiot J, NDao B, Wespiser M, et al TIE-2 expressing monocytic myeloid-derived suppressor cells are involved in
resistance to anti-PD-1 therapy mediated by angiopoietin 2 in melanoma patients.
J Invest Dermatol. 2025 Mar 18:S0022-202X(25)00327. PubMed
MA K, Shafique N, Tortorello G, Dheer A, et al Significance of Prognostic Factors Across Tumor Thicknesses in Melanoma: A
National Cohort Study.
J Invest Dermatol. 2025 Mar 12:S0022-202X(25)00321. PubMed
CHANG J, Shin K, Lewis JM, Suh HW, et al Enhanced Intratumoral Delivery of Immunomodulator Monophosphoryl Lipid A through
Hyperbranched Polyglycerol-Coated Biodegradable Nanoparticles.
J Invest Dermatol. 2025;145:593-604. PubMedAbstract available
February 2025
AZIMI A, Bi L, Bonfil A, Teh R, et al Integrated analysis of proteomic and dermoscopy imaging data improves
non-invasive classification of benign nevi and melanoma.
J Invest Dermatol. 2025 Feb 13:S0022-202X(25)00102. PubMed
WHITESIDE TL Transfer of Oncologic Signals from Melanoma Cells to Benign Melanocytes by
Circulating Tumor-Derived Extracellular Vesicles.
J Invest Dermatol. 2025 Feb 7:S0022-202X(25)00025. PubMed
WONG ZY, Ou KQ, Wong ZN, Faderani R, et al Comment on "Does Sex Matter? Temporal Analyses of Melanoma Trends among Men and
Women Suggest Etiologic Heterogeneity.".
J Invest Dermatol. 2025 Feb 4:S0022-202X(25)00005. PubMed
January 2025
MULLER C, Tschandl P, Rinner C, Kyrgidis A, et al The BRAAFF-Annotated Acral Lesions Dataset (BALD): A curated set of dermatoscopic
images of acral melanoma and nevi from various sources.
J Invest Dermatol. 2025 Jan 17:S0022-202X(25)00021. PubMed
SHEN A, Arbesman M, Lodha R, Rayman P, et al Germline Pathogenic Variant (gPV) Positive Patients with Melanoma Exhibit
Improved Response to Checkpoint Inhibitor Immunotherapy.
J Invest Dermatol. 2025 Jan 13:S0022-202X(25)00004. PubMed
MENG Y, Zhou Q, Dian Y, Zeng F, et al Ferroptosis: A Targetable Vulnerability for Melanoma Treatment.
J Invest Dermatol. 2025 Jan 8:S0022-202X(24)03024. PubMedAbstract available
TRIBBLE JT, Brownell I, Cahoon EK, Sargen MR, et al A comparative study of Merkel cell carcinoma and melanoma incidence and survival
in the United States, 2000-2021.
J Invest Dermatol. 2025 Jan 6:S0022-202X(25)00001. PubMedAbstract available
December 2024
LEE KJ, Kao YC, Smit DJ, Betz-Stablein B, et al Mitochondrial deletion(4977) abundance in melanoma-adjacent skin.
J Invest Dermatol. 2024 Dec 24:S0022-202X(24)03026. PubMed
THAKKER S, Arbesman J, Klein JC, Sunshine JC, et al Three-Dimensional Nuclear Architecture and Genomic Structural Variations in
Melanoma.
J Invest Dermatol. 2024 Dec 24:S0022-202X(24)03032. PubMed
USOLTSEV D, Njauw CN, Ji Z, Kumar R, et al Analysis of variants induced by combined ex vivo irradiation and in vivo
tumorigenesis suggests a role for the ZNF831 p.R1393Q mutation in cutaneous
melanoma development.
J Invest Dermatol. 2024 Dec 13:S0022-202X(24)03015. PubMedAbstract available
HAO J, Xu H, Luo M, Yu W, et al Corrigendum to The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its
Involvement in Response to BRAF-Targeted Therapy [Journal of Investigative
Dermatology, Volume 138, Issue 1, January 2018, Pages 159-170].
J Invest Dermatol. 2024 Dec 6:S0022-202X(24)02184. PubMed
November 2024
LIU X, Janknecht R, Asadbeigi SN, Perry L, et al The influence of melanoma extracellular vesicles on benign melanocytes: a role
for PRAME in modulation of the tumor microenvironment.
J Invest Dermatol. 2024 Nov 26:S0022-202X(24)02959. PubMedAbstract available
SEYRAN B, Avila I, Galvan C, Robles G, et al Inhibition of pyruvate oxidation diminishes melanoma progression.
J Invest Dermatol. 2024 Nov 18:S0022-202X(24)02902. PubMed
GUTIERREZ-GARCIA C, Robles-Espinoza CD MicroRNA Quantification as an Accurate and Cost-Effective Method to Diagnose
Acral Melanoma.
J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02098. PubMed
WEI G, Tran MM, Orsillo L, Mirza FN, et al A Geospatial Analysis of the Association between Access to Tanning Bed Facilities
and Melanoma in the United States New England Region.
J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02172. PubMedAbstract available
September 2024
MEANT A, Moussa O, Lebeau B, Goncalves C, et al Combined inhibition of MNK signaling and BET proteins reveals TGM2 as a novel
vulnerability in melanoma.
J Invest Dermatol. 2024 Sep 30:S0022-202X(24)02160. PubMed
SOLER-SAEZ I, Karz A, Hidalgo MR, Gomez-Cabanes B, et al Unveiling common transcriptomic features between melanoma brain metastases and
neurodegenerative diseases.
J Invest Dermatol. 2024 Sep 24:S0022-202X(24)02149. PubMedAbstract available
CHHABRA G, Ahmad N Mystery of Melanotransferrin in Melanoma.
J Invest Dermatol. 2024 Sep 14:S0022-202X(24)01994. PubMed
August 2024
RUTJES C, Mothershaw A, D'Alessandro BM, Primiero CA, et al Combining Automated Lesion Risk And Change Assessment Improves Melanoma
Detection: A Retrospective Accuracy Study.
J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02060. PubMed
DEACON DC, Stubben C, Marcacci E, Stone CJ, et al Classification of Cutaneous Melanoma and Melanocytic Nevi with microRNA Ratios is
Preserved in the Acral Melanoma Subtype.
J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02063. PubMed
July 2024
GAUDEL C, Pisibon C, Soysouvanh F, Giuliano S, et al Loss of LYN is frequent in targeted-therapy resistant melanoma cells and favors
metastatic properties.
J Invest Dermatol. 2024 Jul 19:S0022-202X(24)01913. PubMed
HASSEL JC, Stanhope S, Greenshields-Watson A, Machiraju D, et al Tebentafusp induces a T cell driven rash in melanocyte-bearing skin as an adverse
event consistent with the mechanism of action.
J Invest Dermatol. 2024 Jul 15:S0022-202X(24)01886. PubMedAbstract available
LATONI DI, Geller A, Semenov YR, Ji Z, et al Geotemporal analysis of melanoma incidence and mortality identifies distinct
clusters of trends within the United States between 2001-2019.
J Invest Dermatol. 2024 Jul 7:S0022-202X(24)01874. PubMedAbstract available
June 2024
CLAUWAERT V, Verhaeghe E, De Schepper S, Haspeslagh M, et al Clinicopathologically Defined Naevus Subtypes and Melanoma Risk.
J Invest Dermatol. 2024 Jun 26:S0022-202X(24)01868. PubMedAbstract available
JANDOVA J, Wondrak GT Melanotransferrin (MELTF, MFI2, CD228) expression attenuates malignant melanoma
progression in the A375-Luc2 murine metastasis model and human patients.
J Invest Dermatol. 2024 Jun 21:S0022-202X(24)01864. PubMed
KAO YC, Stark MS Challenging the Lymph Node Progression Model of Melanoma.
J Invest Dermatol. 2024 Jun 20:S0022-202X(24)00385. PubMed
OLSEN CM, Pandeya N, Miranda-Filho A, Rosenberg PS, et al Does sex matter? Temporal analyses of melanoma trends among men and women suggest
etiologic heterogeneity.
J Invest Dermatol. 2024 Jun 17:S0022-202X(24)01500. PubMedAbstract available
May 2024
NARANPANAWA N, Jayasinghe D, Sturm RA, Betz-Stablein B, et al Automated Detection of Pigmented Iris Freckles using a Deep Neural Network for
Cutaneous Melanoma Risk.
J Invest Dermatol. 2024 May 30:S0022-202X(24)00444. PubMed
April 2024
RANDERSON-MOOR J, Davies J, Harland M, Nsengimana J, et al Systemic inflammation, the peripheral blood transcriptome and primary melanoma.
J Invest Dermatol. 2024 Apr 5:S0022-202X(24)00275. PubMedAbstract available
BEZROOKOVE V, Kianian S, McGeever L, Jones R, et al The molecular evolution of melanoma distant metastases.
J Invest Dermatol. 2024 Apr 4:S0022-202X(24)00271. PubMedAbstract available
March 2024
MOHAMMED NBB, Lau LS, Souchak J, Qiu S, et al Tumor-intrinsic galectin-3 suppresses melanoma metastasis.
J Invest Dermatol. 2024 Mar 6:S0022-202X(24)00169. PubMedAbstract available
February 2024
OLSEN CM, Pandeya N, Whiteman DC Trends in age at melanoma diagnosis according to thickness and histologic subtype
have implications for causality and control.
J Invest Dermatol. 2024 Feb 21:S0022-202X(24)00116. PubMed
ROOKER A, Ouwerkerk W, Bekkenk MW, Luiten RM, et al The Risk of Keratinocyte Cancer in Vitiligo and the Potential Mechanisms
Involved.
J Invest Dermatol. 2024;144:234-242. PubMedAbstract available
January 2024
COLLENNE J, Monnier J, Iguernaissi R, Nawaf M, et al Fusion between an algorithm based on the characterization of melanocytic lesions
asymmetry with an ensemble of CNN for melanoma detection.
J Invest Dermatol. 2024 Jan 29:S0022-202X(24)00078. PubMedAbstract available
JEREMIAN R, Lytvyn Y, Fotovati R, Georgakopoulos JR, et al Distinct signatures of mitotic age acceleration in cutaneous melanoma and
acquired melanocytic nevi.
J Invest Dermatol. 2024 Jan 28:S0022-202X(24)00083. PubMed
NAIMY S, Solberg JBK, Kuczek DE, Lovendorf MB, et al Comparative quantitative proteomic analysis of melanoma subtypes,
nevus-associated melanoma, and corresponding nevi.
J Invest Dermatol. 2024 Jan 5:S0022-202X(23)03211. PubMedAbstract available
November 2023
LEE KJ, Soyer HP, Stark MS The Skin Molecular Ecosystem Holds the Key to Nevogenesis and Melanomagenesis.
J Invest Dermatol. 2023 Nov 1:S0022-202X(23)02918. PubMedAbstract available
September 2023
LIOPYRIS K, Navarrete-Dechent C, Marchetti MA, Rotemberg V, et al Expert agreement on the presence and spatial localization of melanocytic features
in dermoscopy.
J Invest Dermatol. 2023 Sep 7:S0022-202X(23)02577. PubMedAbstract available
HAN JH, Lee S, Ju HJ, Kim M, et al Automated Mass Screening for Comorbidities of Vitiligo Using the National Health
Insurance Database.
J Invest Dermatol. 2023;143:1717-1723. PubMedAbstract available
August 2023
FERRER CC, Marguet T, Vanwonterghem L, Erbek S, et al Serum IGF1 is a prognostic marker for resistance to targeted therapies and a
predictive marker for anti-IGF1R therapy in melanoma.
J Invest Dermatol. 2023 Aug 12:S0022-202X(23)02499. PubMed
VESELY MD, Kidacki M, Gaule P, Gupta S, et al Immune inhibitory molecule PD-1H (VISTA) colocalizes with CD11b myeloid cells in
melanoma and is associated with poor outcomes.
J Invest Dermatol. 2023 Aug 7:S0022-202X(23)02483. PubMedAbstract available
MEHTA PP, Sun M, Betz-Stablein B, Halpern A, et al Improving Artificial Intelligence-Based Diagnosis on Pediatric Skin Lesions.
J Invest Dermatol. 2023;143:1423-1429. PubMedAbstract available
July 2023
AHMED F, Lim R, Moseley I, Hoang M, et al Neighborhood-level Socioeconomic Predictors of Melanoma Thickness, Ulceration,
and Metastasis at a Rhode Island Academic Center.
J Invest Dermatol. 2023 Jul 3:S0022-202X(23)02403. PubMed
PHUNG M, Muralidharan V, Rotemberg V, Novoa RA, et al Best Practices for Clinical Skin Image Acquisition in Translational Artificial
Intelligence Research.
J Invest Dermatol. 2023;143:1127-1132. PubMedAbstract available
May 2023
TORCHIA D Correspondence concerning PTPN11 mosaicism causes a spectrum of pigmentary and
vascular neurocutaneous disorders and predisposes to melanoma.
J Invest Dermatol. 2023 May 24:S0022-202X(23)02127. PubMed
GUO Z, Liu Q, Lan S, Niu N, et al Clinicopathological Features and Prognosis of Melanoma in Northeast China: a
region-based cohort study of 229 consecutive cases.
J Invest Dermatol. 2023 May 17:S0022-202X(23)02069. PubMedAbstract available
FERGUSON J, Eleftheriadou V, Nesnas J RISK OF MELANOMA AND NON-MELANOMA SKIN CANCER IN PEOPLE WITH VITILIGO: UK
POPULATION-BASED COHORT STUDY.
J Invest Dermatol. 2023 May 3:S0022-202X(23)02047. PubMedAbstract available
KANG Y, Ji Z, Li H, Tsao H, et al Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic
Mapping.
J Invest Dermatol. 2023;143:842-853. PubMedAbstract available
April 2023
AKTARY Z, Raymond JH, Pouteaux M, Delmas V, et al Derivation and Use of Cell Lines from Mouse Models of Melanoma.
J Invest Dermatol. 2023;143:538-544. PubMedAbstract available
March 2023
MAROCCHI F, Palluzzi F, Nicoli P, Melixetian M, et al Actionable genetic screens unveil targeting of AURKA, MEK and fatty acid
metabolism as an alternative therapeutic approach for advanced melanoma.
J Invest Dermatol. 2023 Mar 30:S0022-202X(23)01952. PubMedAbstract available
EDDY K, Gupta K, Pelletier JC, Isola AL, et al A SPONTANEOUS MELANOMA MOUSE MODEL APPLICABLE FOR A LONGITUDINAL CHEMOTHERAPY AND
IMMUNOTHERAPY STUDY.
J Invest Dermatol. 2023 Mar 28:S0022-202X(23)01951. PubMedAbstract available
LEICHNER GS, Schweitzer I, Dror S, Levin L, et al Primary melanoma miRNAs trafficking induce lymphangiogenesis.
J Invest Dermatol. 2023 Mar 17:S0022-202X(23)01836. PubMedAbstract available
CHAGANI S, De Macedo MP, Carapeto F, Wang F, et al MULTIPLATFORM ANALYSIS OF INTRATUMORAL PTEN HETEROGENEITY IN MELANOMA.
J Invest Dermatol. 2023 Mar 3:S0022-202X(23)00164. PubMedAbstract available
ERIKSSON I, Vainikka L, Waster P, Ollinger K, et al Lysosomal function and intracellular position determine the malignant phenotype
in malignant melanoma.
J Invest Dermatol. 2023 Mar 3:S0022-202X(23)00171. PubMedAbstract available
February 2023
JOHANSSON PA, Palmer JM, Hamilton HR, Whiteman DC, et al Germline Variants in Childhood Cutaneous Melanoma.
J Invest Dermatol. 2023 Feb 28:S0022-202X(23)00155. PubMed
WANG G, Zeng D, Sweren E, Miao Y, et al m6A RNA methylation correlates with immune microenvironment and immunotherapy
response of melanoma.
J Invest Dermatol. 2023 Feb 24:S0022-202X(23)00095. PubMedAbstract available
RIBERO S, Lambertini M, Ferracin M, Dika E, et al Non-Coding RNA Investigations in Cutaneous Melanoma: a Step forward in
Discovering Novel Biomarkers.
J Invest Dermatol. 2023 Feb 24:S0022-202X(23)00088. PubMed
October 2022
LUU YT, Luo Q, Horner MJ, Shiels M, et al Risk of nonkeratinocyte skin cancers in people living with HIV during the era of
antiretroviral therapy.
J Invest Dermatol. 2022 Oct 7. pii: S0022-202X(22)01942. PubMedAbstract available